This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
U.S. equities rolled over on Thursday. Investors are worried about the fallout from a deepening slide in China’s currency. Foreign exchange markets are rapidly pricing in further trouble for Chinese currency — and Chinese stocks — as President Trump steps up his trade rhetoric. Already, $50 billion in tariffs against Chinese imports are coming in. Another $200 billion are on the way.
0941 WB BNPZY BABA CHLKF CHL BNPQY NYTAB BNPQF BIDU
Good afternoon, and welcome to Skyworks Solutions' Third Quarter Fiscal Year 2018 Earnings Call. This call is being recorded. At this time, I will turn the call over to Mitch Haws, Vice President of Investor Relations for Skyworks. Mr. Haws please go ahead.
CHLKF MS.PRE MS.PRF SW MS.PRG MS.PRA 0941 SWIR SWKS 0762 MS.PRI CHL MS.PRK CHUFF MS CHU
Launched on 06/16/2006, the WisdomTree International High Dividend Fund (DTH - Free Report) is a smart beta exchange traded fund offering broad exposure to the Broad Developed World ETFs category of the market.
0941 BP CHLKF CHL BP BPAQF EFA BP.A BP.B IEFA
HONG KONG (July 18): China Tower, the world's biggest operator of mobile phone network masts, plans to raise up to US$8.8 billion from a Hong Kong listing at a valuation of up to US$35 billion, Thomson Reuters publication IFR reported, citing people close to the deal.
CHJHF CHA GS.PRB GS.PRA GS GLSSP CHUFF JBK CHLKF GSC GS.PRICL TFG GSJ 0941 GS.PRJ GS.PRI BABA 0762 CHL GS.PRD GS.PRC TRI 0728 GJS CHU GS.PRN GS.PRK
Many regard the 21st century as the “Century of Asia.” As America has seen a relative decline, nations — such as China and India — growing their middle classes have placed Asia in a more influential position. Many companies within these countries have also contributed this rise. Although some trade in the U.S. as ADRs, most of these companies trade on the over-the-counter markets, if they trade at all.
500325 CHLKF HXSCF TM RELIANCE INFY NYTAB AIA KIMTY HMC EPI 0941 BABA CHL KIMTF RIGD SNE BIDU TSM RLNIY HXSCL
When the United States implemented its long-publicized $34 billion worth of trade tariffs against China in the first week of July, it prompted a swift retaliation of the same magnitude by the latter. As the battle lines were drawn and shots fired from both sides, the U.S. equity markets remained more or less unfazed by the events and seemingly waited for one of the warring nations to blink first to avert any catastrophic damage.
CHLKF TMUSP TMUS SGH VZA 0941 S CHL VEEV AVGO VZ BRCM QCOM
LONDON (July 17): The US trade ban on Chinese telecom equipment maker ZTE wreaked havoc at wireless carriers in Europe and South Asia and forced operators worldwide to consider broadening their supply networks, industry sources told Reuters.
0941 CHLKF CHL
LONDON (Reuters) - The U.S. trade ban on Chinese telecom equipment maker ZTE wreaked havoc at wireless carriers in Europe and South Asia and forced operators worldwide to consider broadening their supply networks, industry sources told Reuters.
0941 CHLKF CHL
LONDON, July 17 ― The US trade ban on Chinese telecom equipment maker ZTE wreaked havoc at wireless carriers in Europe and South Asia and forced operators worldwide to consider broadening their supply networks, industry sources told Reuters.
0941 CHLKF CHL
In the last five trading days, telecom stocks witnessed a sharp rise initially and maintained a flat trajectory thereafter as the Trump administration imposed tariffs on $34 billion worth of imported goods against China. The stocks resumed its ascent later in the week but slipped partially yesterday, as Washington issued a fresh threat to impose additional tariffs against the communist nation. At the stroke of midnight last Friday, the United States implemented its long- publicized trade tariffs against China, prompting a swift retaliation of the same magnitude by the latter.
CBS LMT CHLKF TMUSP CBS.A TMUS CBS.WD 0941 MSI CHL JNPR ADI NOKIA NOK CPV
Seeking investments that are fairly valued today is like looking for a needle in a haystack. After a 10-year bull market, there are slim pickings in this frothy market. It reminds me of 1998, when I was looking for value stocks during the dot com boom. Everything was richly valued.
0941 PRU MAT CHLKF CHL PRH TEF PFK HBI PJH
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
0941 CHLKF CHL
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...